In vitro delivery of a sparingly water soluble compound from PLA50 microparticles

References

• ADRIEN, J., DESFEMMES, T., M AUDHUIT, C., and HAMON, M., 1993, Effects of two 5-HT(1A) agonists with anxiolytic properties: S 14506 and 20499, on sleep-wakefulness regulations in the rat. European Neuropsychopharmacology, 3, 370.
   Google Scholar
• BARRETT, J. E., and V ANOVER, K. E., 1993, 5-HT receptors as targets for the development of novel anxiolytic drugs: Models, mechanisms and future directions. Psychopharma-cology, 112, 1.
   PubMedGoogle Scholar
• BECK, L. R., CowsAR, D. R., LEWIS, D. H., COSGROVE, R. J., RIDDLE, C. T LowRY, S. L., and EPPERLY, T., 1979, A new long-acting injectable microcapsule system for the administration of progesterone. Fertility and Sterility, 31, 545.
   PubMed Web of Science ®Google Scholar
• Bo:ENDER, R., OH, K. H., and CHEN, H., 1989, The effect of the addition of low molecular weight poly(D,L-lactide) on drug release from biodegradable poly(D,L-lactide) drug delivery systems. International Journal of Pharmacology, 51, 1.
   Google Scholar
• CHDDIJ, W. L., and RIEGELMAN, S., 1971, Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. Journal of Pharmaceutical Science, 60, 1281.
   PubMedGoogle Scholar
• COLPAERT, F. C., KOEK, W ., LEHMANN, J., RIVET, J. M ., LEJEUNE, F., CANTON, H., BERVOETS, K., M ILLAN, M. J., LAumE, M., and LAvIELLE, G., 1992, S14506: A novel, potent, high-efficacy 5-HTIA agonist and potential anxiolytic agent. Drug Development Research, 26, 21.
   Google Scholar
• FONG, J. W., MAULDING, H. V., V ISSCHER, G. E., NAZARENO, J. P., and PEARSON, J. E., 1987, Enhancing drug release from polylactide microspheres by using base in the microencapsulation process. In Controlled Release Technology Pharmaceuticals Applications, edited by P. I. Lee and W. R. Good (Washington DC), p. 214.
   Google Scholar
• FONG, J. W., NAZARENO, J. P., PEARSON, J. E., and MAULDING, H. V., 1986, Evaluation of biodegradable microspheres prepared by solvent evaporation process using sodium oleate as emulsifier. Journal of Controlled Release, 3, 119.
   Google Scholar
• GOUDIE, A. J., and L EATHLEY, M. J., 1994, Assessment of the dependence potential of the potent high-efficacy 5-HT(1A) agonist S14506 in rats. Journal of Psychopharmacol-ogy, 8, 213.
   PubMedGoogle Scholar
• GOULD, P. L., 1983, Methods of following drug release from controlled release dosage forms. British Polymer Journal, 15, 172.
   Google Scholar
• GRIZZI, I G ARREAU, H., LI, S., and VERT, M ., 1995, Biodegradation of devices based on Poly(DL-lactic acid): size dependence. Biomaterials, 16, 305.
   PubMedGoogle Scholar
• HAMON, M ., 1994, Neuropharmacology of anxiety: Perspectives and prospects. Trends in Pharmacological Science, 15, 36.
   PubMedGoogle Scholar
• HARRIS, J. M., 1992, In Poly(ethylene glycol) chemistry biotechnical and biomedical applications, edited by J. M. Harris., Plenum Press 1, New York, USA.
   Google Scholar
• HORA, M. S., RANA, R. K., NUNBERG, J. H., TICE, T. R., GILLEY, R. M., and HUDSON, M. E., 1990, Controlled release of interleukin-2 from biodegradable microspheres. Biol Technology, 8, 755.
   PubMedGoogle Scholar
• IKE, O., S HIMIZU, Y., W ADA, R., HYON, S. H., and IKADA, Y., 1992, Controlled cisplatin delivery system using poly(D,L-lactic acid). Biomaterials, 13, 230.
   PubMedGoogle Scholar
• JALIL, R., and NIXON, J. R., 1990, Microencapsulation using poly(DL-lactic acid) I: Effect of preparative variables on the microcapsule characterisics and release kinetics. Journal of Microencapsulation, 7, 229.
   PubMedGoogle Scholar
• JUNI, K., OGAT A, J., M AT sui, N., KuBoT A, M ., and NAKANO, M., 1985a, Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives. Chemical and Pharmaceutical Bulletin, 33, 1734.
   PubMedGoogle Scholar
• JUNI, K., OGATA, J., M AT SUI, N., KuBoTA, M., and NAKANO, M., 1985b, Control of release rate of bleomycin from polylactic acid microsphers by additives. Chemical and Pharmaceutical Bulletin, 33, 1609.
   PubMedGoogle Scholar
• KISHDDA, A., DREssmAN, J. B., YosmoKA, S., Aso, Y., and TAKEDA, Y., 1990, Some determinants of morphology and release rate from poly(L)lactic acid microspheres. Journal of Controlled Release, 13, 83.
   Google Scholar
• LACROUC, P., R OCHER, N., MARTIN, P., and MOCAER, E., 1993, Antidepressant effects of S14506 in the learned helplessness test in rats. European Neuropsychopharmacology, 3, 347. LANGER, R. S., and PEPPAS, N. A., 1981, Present and future applications of Biomaterials. Biomaterials, 2, 201.
   Google Scholar
• LAVIELLE, G., LAUBIE, M., and CoLPAERT, F., 1991, 1-Naphthylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them. Eur. Pat. Appl. EP 434,561 (Cl. C07D295/12).
   Google Scholar
• MARIETTE, B., COUDANE, J., VERT, M., GAUTIER, J. C., and MONETON, P., 1993, Release of the GRF29NH2 analog of human GRF44NH2 from a PLA/GA matrix. Journal of Controlled Release, 24, 237.
   Google Scholar
• MAULDING, H. V., TICE, T. R., COWSAR, D. R., FONG, J. W., PEARSON, J. E., and NAZARENO, J. P., 1986, Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. Journal of Controlled Release, 3, 103.
   Google Scholar
• MILLAN, M. J., CANTON, H., and LAVIELLE, G., 1992, Targeting multiple serotonin receptors: Mixed 5-HT (1A) agonists/5- HT (1C/2) antagonists as therapeutic agents. Drug News Perspectives, 5, 397.
   Google Scholar
• MILLAN, M. J., RIVET, J. M., CANTON, H., LE MARouILLE-GIRARDON, S., and GOBERT, A., 1993, Induction of hypothermia as a model of 5-hydroxytryptamine (1A) receptor-mediated activity in the rat: A pharmacological characterization of the actions of novel agonists and antagonists. Journal of Pharmacological Experimental Therapy, 264, 1364, cited p2, ligne 3.
   Google Scholar
• POIRIER-LITTRE, M. F., 1989, Systeme sdrotoninergique et depression. Conference de L'Institut Pasteur, p. 3, Paris, France, "Implication du mdtabolisme de la sdrotonine dans la ddpression" (Paris: Masson).
   Google Scholar
• PROTAIS, P., CHAGRAOUI, A., ARBAOUI, J., and MOCAER, E., 1993a, Effects of chronic treatments with S14506, haloperidol and raclopride on apomorphine-induced behaviours in mice. European Neuropsychopharmacology, 3, 397.
   Google Scholar
• PROTAIS, P., CHAGRACUI, A., ARBAOUI, J., and MOCAER, E., 1993b, Atypical neuroleptic profile of S14506, a high affinity 5-HT(1A) agonist with D-2 and 5-HT(1C) antagonist activities. European Neuropsychopharmacology, 3, 396.
   Google Scholar
• PROTAIS, P., CHAGRAouI, A., ARRAouI, J., and MOCAER, E., 1994, Dopamine receptor antagonist properties of S14506, 8-0H-DPAT, raclopride and clozapine in rodents. European Journal of Pharmaceuties, 271, 167.
   PubMedGoogle Scholar
• ROGERS, J. A., and OWUSE-ABADIO, G., 1994, An open chemostat system to optimize the formulation of sustained release products. Proceedings of the International Symposium Controlled Release in Bioactive Materials, Controlled Release Society, Inc., 21, 497.
   Google Scholar
• SABOE, J. C., and DEMPSKI, R. E., 1976, Physical-chemical factors affecting the preparation of a coarse solid dispersion by crystallisation of indomethacin from a metastable solid solution. Drug Development Communications, 2, 359.
   Google Scholar
• SAVE, T., and VENKITACHALAK P., 1992, Studies on solid dispersions of nifedipine. Drug Developments in Pharmacy, 18, 1663.
   Google Scholar
• SCHWACYLI, G., COUDANE, J., ENGEL, R., and VERT, M., 1994, Stannous octoate versus zinc initiated polymerization of racemic lactide. Effects on configurational structures. Polymer Bulletin, 32, 617.
   Google Scholar
• SMITH, A., and HUNNEYBALL, I. M., 1986, Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration. International Journal of Pharmacy, 30, 215.
   Google Scholar
• SPENLEHAUER, G., 1987, PhD thesis, University of Paris Sud, France.
   Google Scholar
• SPENLEHAUER, G., VEILLARD, M., and BENOIT, J. P., 1986, Formation and characterization of cisplatin loaded poly(D,u-lactide) microspheres for chemoembolization. Journal of Pharmaceutical Science, 75, 750.
   PubMedGoogle Scholar
• SPENLEHAUER, G., VERT, M., BENOIT, J. P., and BODDAERT, A., 1989, In vitro and in vivo degradation of poly(D,L-lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials, 10, 557.
   PubMedGoogle Scholar
• SPENLEHAUER, G., VERT, M., BENOIT, J. P., CHABOT, F., and VEILLARD, M., 1988, Biodegradable cisplatin microspheres prepared by the solvent evaporation method: Morphology and release characteristics. Journal of Controlled Release, 7, 217.
   Google Scholar
• SUMU, K., and PRICE, J. C., 1976, Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(D,L-lactide). Journal of Pharmaceutical Science, 65, 1613.
   PubMedGoogle Scholar
• TABATA, T., TAKEBAYASHI, Y., UEDA, T., and IKADA, Y., 1993, A formulation method using D,L-lactic acid oligomer for protein release with reduced initial burst. Journal of Controlled Release, 23, 55.
   Google Scholar
• TICE, T. R., and GILLEY, R. M., 1985, Preparation of injectable controlled release microcapsules by solvent evaporation process. Journal of Controlled Release, 2, 343.
   Google Scholar
• VENKAT ARAM, S., and RooERS, J. A., 1984, Characteristics of drug-phospholipid coprecipitates I: Physical properties and dissolution behavior of griseofulvin-dimyristoylphosphatidylcholine systems. Journal of Pharmaceutical Science, 73, 757.
   PubMedGoogle Scholar
• VENKATARAM, S., and ROGERS, J. A., 1985, Controlled release of griseofulvin from coprecipitates with phospholipids. Drug Developments in Industrial Pharmacy, 11, 223.
   Google Scholar
• VERRECHIA, T., HUVF„ P., BAZILF„ D., V EILLARD, M., SPENLEHAUER, G., and COUVREUR, P., 1993, Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. Journal of Biomedical Materials Research, 27, 1019.
   Google Scholar
• VUDAT HALA, G. K., and R OGERS, J. A., 1984, Microencapsulation of solid dispersions: Release of griseofulvin from griseofulvin-phospholipid coprecipitates in micro-spheres. Pharmaceutical Research, 9, 759.
   Google Scholar
• WISE, D. L., 1984, In Biopolymeric Controlled Release Systems, edited by D. L. Wise "Polyesters from Krebs cycle monomers as vehicles for sustained release" (Boca Raton, FL: CRC Press), vol. 1, p. 187.
   Google Scholar
• YEH, M. K., JENKINs, P. G., DAVIS, S. S., and C OM BES, A. G. A., 1995, Improving the delivery capacity of microparticle systems using blends of poly(DL-lactide co-glycolide) and poly(ethylene glycol). Journal of Controlled Release, 37, 1.
   Google Scholar
• YOLLES, S., LEAFE, T. D., WooDLAND, J. H. R., and MEYER, F. J., 1975, Long-acting delivery systems for narcotic antagonists. II: Release rate of naltrexone from poly(lactic acid) composites. Journal of Pharmaceutical Science, 64, 348.
   PubMedGoogle Scholar
• ZHOU, M. X., and CHANG, T. M. S., 1988, TMS: Controlled release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles. Journal of Microencapsulation, 5, 27.
   PubMedGoogle Scholar